Rivista di formazione e aggiornamento di pediatri e medici operanti sul territorio e in ospedale. Fondata nel 1982, in collaborazione con l'Associazione Culturale Pediatri
Gli articoli più visti nel mese di Agosto 2025
98 kB2) La pagina gialla - Giugno 2025
a cura di Sara Lega
6) Farmacoriflessioni - Giugno 2025
Trattamento della scabbia
- Sapigni E, Nigro R, Mattei G, Matteo G, Di Nuzzo S, Motolese A, Corazza M, Conti A, Marchetti F.
- Scabies, a parasitic dermatosis caused by Sarcoptes scabiei, is classified by the World Health Organization as a neglected tropical disease due to its global burden. In recent years, the Emilia-Romagna Region has reported a significant increase in scabies cases, with higher incidence among males, children, adolescents and young adults. This guideline aims to provide evidence-based recommendations for the diagnosis, treatment and management of scabies, by focusing on target populations and types of scabies, with specific consideration for paediatric patients. The guideline was developed by a multidisciplinary team of dermatologists, paediatricians, public health officials and pharmacists from the Emilia-Romagna Region. It is based on systematic reviews, meta-analyses and international guidelines published in the last six years (2019-2024). Permethrin 5% topical cream remains the first-line therapy. Benzyl benzoate and oral ivermectin are effective alternatives in selected cases; oral ivermectin is specifically recommended for treating large groups or patients with extensive eczema. Crusted scabies requires a combination of topical and systemic agents, along with keratolytics. Early treatment of close contacts and a structured two-week follow-up are also recommended. A practical section on paediatric topical application is included to assist caregivers and improve compliance. This guideline supports healthcare professionals in the standardised management of scabies and emphasizes the need for effective interventions to address the rising incidence of cases.
7) Aggiornamento - Giugno 2025
I disturbi respiratori ostruttivi del sonno
- Basilicata S, Traunero A, Borrelli M, Maschio M, Ghirardo S, Amaddeo A.
- Obstructive sleep disordered breathing encompasses different clinical entities, the most severe of which is obstructive sleep apnea syndrome (OSAS). Children with severe adenotonsillar hypertrophy, obesity, congenital malformations or specific syndromes are most likely to develop OSAS. Even though the diagnostic gold standard is polysomnography (PSG), alternative diagnostic tools are currently more used and seem to be more cost-effective and less time-consuming for families and sleep technicians. Therapeutic approach may be pharmaceutical, surgical or, in more severe cases, needs ventilation therapy.
9) Aggiornamento - Aprile 2008
L'ipertensione arteriosa in età pediatrica: dall'inquadramento diagnostico alla terapia
- A. de Cunto, M. Maschio, M. Pennesi, A. Benettoni
- The epidemic of childhood obesity, the risk of developing left ventricular hypertrophy, and evidence of the early development of atherosclerosis in children would make identification and treatment of hypertension an important focus of physicians caring for children. Secondary hypertension is more common in preadolescent children, with most cases caused by renal disease. Primary or essential hypertension is an emerging condition in adolescents and has multiple risk factors, including obesity and a family history of hypertension. Evaluation involves a thorough history and physical examination, laboratory tests, and specialized studies. Lifestyle modifications are advised for all patients and can be tried solely for those with blood pressures between the 95th and 99th percentiles. Drug therapy is indicated in children with blood pressures greater than the 99th percentile, secondary hypertension, coexisting diabetes, left ventricular hypertrophy, or those who fail a trial of non pharmacologic treatment.
10) Aggiornamento - Ottobre 2007
La splenomegalia
- M. Rabusin, F. Patarino
- The spleen in infants and children is involved in a wide variety of pathological conditions. Splenic disorders may be isolated like splenic cysts or, more frequently, due to multiorgan or systemic disease including hepatic diseases, malignancy, hemoglobinopathy, infectious diseases and storage diseases. The Authors review the role of the laboratory test, the ultrasonography and the peripheral blood smear in orienting the differential diagnosis. Invasive procedure as bone marrow aspiration, lymph node biopsy, hepatic biopsy or fine needle splenic biopsy are often warranted to estabilish the cause of splenomegaly.